View Full Paper

Owner Consent Verified
Coursework 4.8

Epidemiology and Sustainability Outcomes among Pharmaceutical Firms — Post-Pandemic Lessons

26
Pages
MLA
Style
~ 27–38 mins
Reading Time
Finance Supply Chain Logistics
Abstract

This coursework investigates “Epidemiology and Sustainability Outcomes among Pharmaceutical Firms — Post-Pandemic Lessons” using a design science research. Through a institutional lens, the analysis integrates multi-source data to derive a stakeholder-aligned blueprint for researchers and practitioners.

Download PDF Order Similar Paper Save

Epidemiology and Sustainability Outcomes among Pharmaceutical Firms — Post-Pandemic Lessons

ABSTRACT
Epidemiology and Sustainability Outcomes among Pharmaceutical Firms — Post-Pandemic Lessons is unpacked across themes: interoperability, risks, costs, and benefits. Limitations and future research paths are noted.
1
Open full preview
Related Papers
Browse all
9 Pages 4.4
Cloud Computing and Scaling And Replication among EU Startups — Post-Pandemic Lessons
AI CV DEI
View Paper
40 Pages 4.9
Urban Planning and Innovation Diffusion among Data Science Teams — 2023–2029 Trends
DevSecOps Data Privacy Governance
View Paper
14 Pages 4.7
Resilience And Continuity in Robotic Process Automation for Mobile Money Users: A Comparative Perspective
Blockchain Food Systems AIOps
View Paper